Abstract
T lymphocytes are required for cell-mediated immunity but also give rise to immunological diseases such as autoimmunity and transplantation rejection. Intracellular serine protease inhibitors (serpinsIC) regulate the activity of key of proteases that control T lymphocyte function and development. An emerging view of serpinsIC is that they are important promoters of cellular viability through their inhibition of executioner proteases. This will be discussed in the context of the T lymphocyte survival during effector responses and the development and persistence of long-lived memory T cells. The potent anti-apoptotic properties of serpins can also work against adaptive cell immunity by protecting viruses and tumors from eradication by cytotoxic T cells (CTL). Recent insights from knockout mouse models demonstrate that these serpins also are required for hematological progenitor cells and so are critical for the development of lineages other than T lymphocytes. Given the emerging role of serpins in multiple aspects of lymphocyte immunity and blood development, this chapter will examine new immunotherapeutic approaches based directly on serpins or on knowledge gained from identifying their physiologically relevant protease targets.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Ahmed R, Gray D (1996) Immunological memory and protective immunity: understanding their relation. Science 272(5258):54–60
Annand RR, Dahlen JR, Sprecher CA, De Dreu P, Foster DC, Mankovich JA, Talanian RV, Kisiel W, Giegel DA (1999) Caspase-1 (interleukin-1beta-converting enzyme) is inhibited by the human serpin analogue proteinase inhibitor 9. Biochem J 342(Pt 3):655–665
Ansari AW, Temblay JN, Alyahya SH, Ashton-Rickardt PG (2010) Serine protease inhibitor 6 protects iNKT cells from self-inflicted damage. J Immunol 185(2):877–883. doi:10.4049/jimmunol.1000651, jimmunol.1000651 [pii]
Ashton-Rickardt PG (2010) Serine protease inhibitors and cytotoxic T lymphocytes. Immunol Rev 235(1):147–158. doi:10.1111/j.0105-2896.2010.00892.x
Azzi J, Ohori S, Ting C, Uehara M, Abdoli R, Smith BD, et al. (2015) Serine protease inhibitor-6 differentially affects the survival of effector and memory alloreactive CD8-T cells. American Journal of Transplantation 15:234–241. doi:10.1111/ajt.13051
Azzi J, Skartsis N, Mounayar M, Magee CN, Batal I, Ting C, Moore R, Riella LV, Ohori S, Abdoli R, Smith B, Fiorina P, Heathcote D, Bakhos T, Ashton-Rickardt PG, Abdi R (2013) Serine protease inhibitor 6 plays a critical role in protecting murine granzyme B-producing regulatory T cells. J Immunol 191(5):2319–2327. doi:10.4049/jimmunol.1300851
Becker TC, Coley SM, Wherry EJ, Ahmed R (2005) Bone marrow is a preferred site for homeostatic proliferation of memory CD8 T cells. J Immunol 174(3):1269–1273, 174/3/1269 [pii]
Bladergroen BA, Meijer CJ, ten Berge RL, Hack CE, Muris JJ, Dukers DF, Chott A, Kazama Y, Oudejans JJ, van Berkum O, Kummer JA (2002) Expression of the granzyme B inhibitor, protease inhibitor 9, by tumor cells in patients with non-Hodgkin and Hodgkin lymphoma: a novel protective mechanism for tumor cells to circumvent the immune system? Blood 99(1):232–237
Bladergroen BA, Strik MC, Bovenschen N, van Berkum O, Scheffer GL, Meijer CJ, Hack CE, Kummer JA (2001) The granzyme B inhibitor, protease inhibitor 9, is mainly expressed by dendritic cells and at immune-privileged sites. J Immunol 166:3218–3225
Byrne SM, Aucher A, Alyahya S, Elder M, Olson ST, Davis DM, Ashton-Rickardt PG (2012) Cathepsin B controls the persistence of memory CD8+ T lymphocytes. J Immunol 189(3):1133–1143. doi:10.4049/jimmunol.1003406, jimmunol.1003406 [pii]
Dev A, Byrne SM, Verma R, Ashton-Rickardt PG, Wojchowski DM (2013) Erythropoietin-directed erythropoiesis depends on serpin inhibition of erythroblast lysosomal cathepsins. J Exp Med. doi:10.1084/jem.20121762, jem.20121762 [pii]
El Haddad N, Heathcote D, Moore R, Yang S, Azzi J, Mfarrej B, Atkinson M, Sayegh MH, Lee JS, Ashton-Rickardt PG, Abdi R (2011a) Mesenchymal stem cells express serine protease inhibitor to evade the host immune response. Blood 117(4):1176–1183. doi:10.1182/blood-2010-06-287979, blood-2010-06-287979 [pii]
El Haddad N, Moore R, Heathcote D, Mounayar M, Azzi J, Mfarrej B, Batal I, Ting C, Atkinson M, Sayegh MH, Ashton-Rickardt PG, Abdi R (2011b) The novel role of SERPINB9 in cytotoxic protection of human mesenchymal stem cells. J Immunol 187(5):2252–2260. doi:10.4049/jimmunol.1003981, jimmunol.1003981 [pii]
Forsyth S, Horvath A, Coughlin P (2003) A review and comparison of the murine alpha1-antitrypsin and alpha1-antichymotrypsin multigene clusters with the human clade A serpins. Genomics 81(3):336–345, S0888754302000411 [pii]
Godfrey DI, MacDonald HR, Kronenberg M, Smyth MJ, Van Kaer L (2004) NKT cells: what's in a name? Nat Rev Immunol 4(3):231–237. doi:10.1038/nri1309
Heath WR, Belz GT, Behrens GM, Smith CM, Forehan SP, Parish IA, Davey GM, Wilson NS, Carbone FR, Villadangos JA (2004) Cross-presentation, dendritic cell subsets, and the generation of immunity to cellular antigens. Immunol Rev 199:9–26. doi:10.1111/j.0105-2896.2004.00142.xIMR142
Hirst CE, Buzza MS, Bird CH, Warren HS, Cameron PU, Zhang M, Ashton-Rickardt PG, Bird PI (2003) The intracellular granzyme b inhibitor, proteinase inhibitor 9, is up-regulated during accessory cell maturation and effector cell degranulation, and its overexpression enhances CTL potency. J Immunol 170:805–815
Huang JF, Yang Y, Sepulveda H, Shi W, Hwang I, Peterson PA, Jackson MR, Sprent J, Cai Z (1999) TCR-Mediated internalization of peptide-MHC complexes acquired by T cells. Science 286(5441):952–954
Jacob J, Baltimore D (1999) Modelling T-cell memory by genetic marking of memory T cells in vivo. Nature 399(6736):593–597
Joshi NS, Cui W, Chandele A, Lee HK, Urso DR, Hagman J, Gapin L, Kaech SM (2007) Inflammation directs memory precursor and short-lived effector CD8(+) T cell fates via the graded expression of T-bet transcription factor. Immunity 27(2):281–295
Li L, Byrne SM, Rainville N, Su S, Jachimowicz E, Aucher A, Davis DM, Ashton-Rickardt PG, Wojchowski DM (2014) Brief report: serpin Spi2A as a novel modulator of hematopoietic progenitor cell formation. Stem Cells 32(9):2550–2556. doi:10.1002/stem.1778
Lieberman J (2003) The ABCs of granule-mediated cytotoxicity: new weapons in the arsenal. Nat Rev Immunol 3:361–370
Liu N, Phillips T, Zhang M, Wang Y, Opferman JT, Shah R, Ashton-Rickardt PG (2004a) Serine protease inhibitor 2A is a protective factor for memory T cell development. Nat Immunol 5(9):919–926
Liu N, Raja SM, Zazzeroni F, Metkar SS, Shah R, Zhang M, Wang Y, Bromme D, Russin WA, Lee JC, Peter ME, Froelich CJ, Franzoso G, Ashton-Rickardt PG (2003) NF-kappaB protects from the lysosomal pathway of cell death. EMBO J 22(19):5313–5322
Liu N, Wang Y, Ashton-Rickardt PG (2004b) Serine protease inhibitor 2A inhibits caspase-independent cell death. FEBS Lett 569(1-3):49–53
Lovo E, Zhang M, Wang L, Ashton-Rickardt PG (2012) Serine protease inhibitor 6 is required to protect dendritic cells from the kiss of death. J Immunol 188(3):1057–1063. doi:10.4049/jimmunol.1102667, jimmunol.1102667 [pii]
Medema JP, de Jong J, Peltenburg LT, Verdegaal EM, Gorter A, Bres SA, Franken KL, Hahne M, Albar JP, Melief CJ, Offringa R (2001a) Blockade of the granzyme B/perforin pathway through overexpression of the serine protease inhibitor PI-9/SPI-6 constitutes a mechanism for immune escape by tumors. Proc Natl Acad Sci USA 98(20):11515–11520
Medema JP, Schuurhuis DH, Rea D, van Tongeren J, de Jong J, Bres SA, Laban S, Toes RE, Toebes M, Schumacher TN, Bladergroen BA, Ossendorp F, Kummer JA, Melief CJ, Offringa R (2001b) Expression of the serpin serine protease inhibitor 6 protects dendritic cells from cytotoxic T lymphocyte-induced apoptosis: differential modulation by T helper type 1 and type 2 cells. J Exp Med 194(5):657–667
Opferman JT, Letai A, Beard C, Sorcinelli MD, Ong CC, Korsmeyer SJ (2003) Development and maintenance of B and T lymphocytes requires antiapoptotic MCL-1. Nature 426(6967):671–676
Opferman JT, Ober BT, Ashton-Rickardt PG (1999) Linear differentiation of cytotoxic effectors into memory T lymphocytes. Science 283(5408):1745–1748
Phillips T, Opferman JT, Shah R, Liu N, Froelich CJ, Ashton-Rickardt PG (2004) A role for the granzyme B inhibitor serine protease inhibitor 6 in CD8+ memory cell homeostasis. J Immunol 173(6):3801–3809
Remold-O’Donnell E (1993) The ovalbumin family of serpin proteins. FEBS Lett 315(2):105–108
Russell JH, Ley TJ (2002) Lymphocyte-mediated cytotoxicity. Annu Rev Immunol 20:323–370
Stepp SE, Dufourcq-Lagelouse R, Le Deist F, Bhawan S, Certain S, Mathew PA, Henter J-I, Bennett M, Fischer A, de Saint Basile G, Kumar V (1999) Perforin gene defects in familial hemophagocytic lymphohistiocytosis. Science 286:1957–1959
Sun J, Bird CH, Sutton V, McDonald L, Coughlin PB, De Jong TA, Trapani JA, Bird PI (1996) A cytosolic granzyme B inhibitor related to the viral apoptotic regulator cytokine response modifier a is present in cytotoxic lymphocytes. J Biol Chem 271(44):27802–27809
Sun J, Ooms L, Bird CH, Sutton VR, Trapani JA, Bird PI (1997) A new family of 10 murine ovalbumin serpins includes two homologs of proteinase inhibitor 8 and two homologs of the granzyme B inhibitor (proteinase inhibitor 9). J Biol Chem 272(24):15434–15441
ten Berge RL, Meijer CJ, Dukers DF, Kummer JA, Bladergroen BA, Vos W, Hack CE, Ossenkoppele GJ, Oudejans JJ (2002) Expression levels of apoptosis-related proteins predict clinical outcome in anaplastic large cell lymphoma. Blood 99(12):4540–4546
Walden PR, Eisen HN (1990) Cognate peptides induce self-destruction of CD8+ cytolytic T lymphocytes. Proc Natl Acad Sci USA 87:9015–9019
Willoughby CA, Bull HG, Garcia-Calvo M, Jiang J, Chapman KT, Thornberry NA (2002) Discovery of potent, selective human granzyme B inhibitors that inhibit CTL mediated apoptosis. Bioorg Med Chem Lett 12(16):2197–2200
Wojchowski DM, Sathyanarayana P, Dev A (2010) Erythropoietin receptor response circuits. Curr Opin Hematol 17(3):169–176. doi:10.1097/MOH.0b013e328338008b
Young JL, Sukhova GK, Foster D, Kisiel W, Libby P, Schonbeck U (2000) The serpin proteinase inhibitor 9 is an endogenous inhibitor of interleukin 1beta-converting enzyme (caspase-1) activity in human vascular smooth muscle cells. J Exp Med 191(9):1535–1544
Zhang M, Byrne S, Liu N, Wang Y, Oxenius A, Ashton-Rickardt PG (2007) Differential survival of cytotoxic T cells and memory cell precursors. J Immunol 178(6):3483–3491
Zhang M, Park SM, Wang Y, Shah R, Liu N, Murmann AE, Wang CR, Peter ME, Ashton-Rickardt PG (2006) Serine protease inhibitor 6 protects cytotoxic T cells from self-inflicted injury by ensuring the integrity of cytotoxic granules. Immunity 24(4):451–461
Acknowledgments
The author thanks his collaborators for generating the data, published and unpublished that formed the basis of this review.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Ashton-Rickardt, P.G. (2015). Serpins in T Lymphocyte Immunity and Blood Development. In: Geiger, M., Wahlmüller, F., Furtmüller, M. (eds) The Serpin Family. Springer, Cham. https://doi.org/10.1007/978-3-319-22711-5_7
Download citation
DOI: https://doi.org/10.1007/978-3-319-22711-5_7
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-22710-8
Online ISBN: 978-3-319-22711-5
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)